Please provide your email address to receive an email when new articles are posted on . Alcon completed the acquisition of Belkin Vision, including its direct selective laser trabeculoplasty ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Long of Alcon introduces some of the ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager ™ DSLT, the ...

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

Alcon has announced the US release of its Voyager direct selective laser trabeculoplasty (DSLT) platform, with a launch event scheduled for the American Glaucoma Society annual meeting later in ...

Looking back, glaucoma specialists like Dr. Christine Funke of Barnet Dulaney Perkins Eye Center can remember a time not long ago when treatment options for the eye condition were greatly limited.

UK researchers have highlighted that long-term use of topical anti-glaucoma medication is associated with an adverse effect ...